Josh Berman

Josh Berman joined ALS Therapy Development Institute in October 2019. He works in the Precision Medicine Program, processing patient blood samples as they are returned and evaluating potential blood-based biomarkers of ALS. He is a recent graduate of Boston University with a Bachelor's Degree cum laude in Neuroscience and a Minor in Mathematics. He has previously worked with Dr. Shlomo Wagner at the University of Haifa, studying the social behavior of mouse models of Autism Spectrum Disorder, and potential drug therapies within these models. He has also worked in cellular-based models of beta-amyloid plaques associated with Alzheimer's Disease, and in rat-based tauopathy models of Alzheimer's Disease as well. Looking to build upon past experience in immunology and animal models, he is looking to continue working on the front lines of neurodegenerative disease, and uncover potential therapies or drug targets through his clinical work at ALS TDI.